ClinicalTrials.Veeva

Menu

The Role of TextRAd on Detection of Liver Metastasis in Rectal Cancer

E

East Suffolk and North Essex NHS Foundation Trust

Status

Completed

Conditions

Rectal Cancer

Treatments

Diagnostic Test: MRI

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a retrospective analysis of all patients diagnosed with LARC who received NCRT and had MRI scans between 2003-2014 at East Suffolk and North Essex NHS Foundation Trust. Region of interest was drawn around the tumor or its location on T2 MRI images. Six texture parameters were systematically extracted from Textural histograms of post-treatment scans. These parameters were examined to determine their ability to predict local recurrence and distant metastases through Kaplan-Meier survival curves and log-rank tests.

Enrollment

113 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All subjects must have MRI post-Chemotherapy treatment to detect the response to Neoadjuvant treatment and compare it to pre-treatment scans to easily determine if there were a posttreatment liver metastasis.
  • Locally advanced rectal cancer (LARC) = MRI stage: T3/T4 and/or N1/N0.

Exclusion criteria

  • Distant metastases.
  • Synchronous tumour.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems